VA Spent $370 Million On Sovaldi And Olysio In Fiscal 2014
This article was originally published in The Pink Sheet Daily
Executive Summary
VA's discount negotiation powers cut price per dose to almost half of commercial levels, discussion at Senate hearing reveals. HCV drug costs for VA could top $1 billion for next two years.